Navigation Links
Gene Test May Help Predict Success of Weight-Loss Surgery
Date:5/2/2013

By Brenda Goodman
HealthDay Reporter

THURSDAY, May 2 (HealthDay News) -- Weight loss after gastric bypass surgery varies widely, and scientists say they have identified a genetic variation that may help explain the discrepancy.

The discovery, detailed in a study published May 2 in the American Journal of Human Genetics, is already driving creation of a gene test that may one day help patients predict how many pounds they might shed after weight-loss surgery.

Some patients lose 60 percent of their weight after the surgery, and others just 15 percent. Factors such as age, activity level and whether a patient has other health problems, such as diabetes, help doctors estimate a patient's potential results.

But sometimes, patients who seem like great candidates for the surgery don't slim down as much as they'd hoped.

"This is heartbreaking for those folks who have been brave enough and struggled enough to get to the point of having surgery and then experience failure in terms of weight loss," said Molly Bray, a professor of epidemiology at the University of Alabama at Birmingham, who was not involved in the research.

"Identifying markers that can predict response to surgery prior to its undertaking would be extremely important," said Bray, whose research involves the genetic basis of obesity.

For the new study, researchers surveyed the genomes of more than 1,000 patients who had Roux-en-Y gastric bypass surgery, where surgeons seal off the upper portion of the stomach to make a smaller pouch and then connect that to the middle portion of the small intestine.

One location turned out to be significantly associated with weight loss after surgery.

The location in question doesn't lie within a gene. Genes contain instructions that tell the body to make specific proteins. Instead, it seems to sit in a stretch of DNA between two genes on chromosome 15. The researchers said they're not sure how differences in DNA in that region might influence weight loss, but it may control the adjacent genes, which seem to play a role.

Looking at the different variants at this location, the researchers found that people with two copies of the more common variant lost an average of 39 percent of their starting weight, while the one person in the study who had two copies of the less common variant shed 29 percent of starting weight.

Patients with just a single copy of the less common DNA variant were 2.5 times more likely to lose less than 30 percent of their total bodyweight after surgery than patients without that variant.

Next, researchers checked the activity of the two genes closest to the location of the gene variant.

People with greater expression of the gene closest to the variant in their abdominal fat lost more weight after surgery than those with less gene activity there. That remained true even after researchers adjusted their results for factors such as age, sex, diabetes and body-mass index (a measure of body fat based on a person's ratio of height and weight) before surgery.

To check their results another way, they also looked at the activity of two genes closest to the variant in obese mice given either a gastric bypass or sham surgery. Ten months after the procedures, the gene expression in mice that had gastric bypass was different than in mice that had sham surgeries.

"There's an enormous amount of biology that's changed in response to the surgery," said Dr. Lee Kaplan, director of the Obesity, Metabolism, & Nutrition Institute at Massachusetts General Hospital, in Boston.

Doctors once thought patients lost weight after gastric bypass simply because their stomachs were smaller, allowing them to feel full after eating a lot less.

But recent studies have shown the surgery also alters hormones, gut microbes and the activity of genes.

"That's probably why surgery is so effective clinically, because it does so much," Kaplan said.

Kaplan's team is developing a test to look for patterns in gene activity that he says will be available within a year. It will take a few years beyond that to validate the test and secure U.S. Food and Drug Administration approval, he added.

Such a test could help patients who are on the fence about having the weight-loss procedure, he said. Gastric bypass can be very beneficial for severely obese people, but also carries some risk, especially for those with other significant health problems.

Further studies are needed to clarify the role of the genetic variation identified in the study and, because most of this study's participants were of European descent, to look for other variants that might apply to different ethnic groups.

Kaplan said he also wants to see if they might get the same results with other kinds of weight-loss procedures.

"Genetics makes a contribution to weight loss after surgery. This has put the wind in our sails so now we can go after other questions," he said.

More information

For more information about weight-loss surgery, visit the U.S. National Institute of Diabetes and Digestive and Kidney Diseases.

SOURCES: Lee Kaplan, M.D., Ph.D., director, Obesity, Metabolism, & Nutrition Institute, Massachusetts General Hospital, Boston; Molly Bray, Ph.D., professor of epidemiology, University of Alabama at Birmingham; May 2, 2013, American Journal of Human Genetics


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Psychological testing may predict success in soccer
2. Predictors identified for rehospitalization among post-acute stroke patients
3. Can a standard vision test predict nighttime driving performance?
4. EKG Heart Test May Predict Risk in Older Adults
5. New MRI technique may predict progress of dementias
6. Symptomatic behaviour in childhood strongly predicts psychiatric treatment as a young adult
7. Small neural focus groups predict anti-smoking ad success
8. Can Blood Test Predict Breast Cancer Risk?
9. Hormone may help predict tubal ectopic pregnancy
10. New technique predictably generates complex, wavy shapes
11. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Test May Help Predict Success of Weight-Loss Surgery
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: